Savara (SVRA) Asset Utilization Ratio (2013 - 2022)

Savara (SVRA) posted quarterly Asset Utilization Ratio of 0.0 for Q1 2022, down 99.59% quarter-over-quarter from 0.0 in Q4 2021.

Savara (SVRA) Asset Utilization Ratio (2013 - 2022) Analysis & Trends

Savara (SVRA) has reported Asset Utilization Ratio for 8 consecutive years, with 0.0 the latest figure, recorded in Q1 2022.

In Q1 2022, Asset Utilization Ratio changed N/A year-over-year to 0.0; the TTM figure through Mar 2022 stood at 0.0 (changed N/A YoY), while the FY2020 annual figure was 0.0, changed N/A from the prior year.
Asset Utilization Ratio retreated to 0.0 in Q1 2022 per SVRA's latest filing, from 0.0 in the prior quarter.
Across five years, Asset Utilization Ratio topped out at 0.0 in Q4 2020 and bottomed at 0.0 in Q1 2022.
Historically, Asset Utilization Ratio has averaged 0.0 across 3 years, with a median of 0.0 in 2021.
On a YoY basis, Asset Utilization Ratio climbed as much as 7.19% in 2021 and fell as far as 43.09% in 2021.
Savara's Asset Utilization Ratio stood at 0.0 in 2020, then tumbled by 43.09% to 0.0 in 2021, then plunged by 99.59% to 0.0 in 2022.
Business Quant data shows SVRA's Asset Utilization Ratio at 0.0 in Q1 2022, 0.0 in Q4 2021, and 0.0 in Q3 2021.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Asset Util. (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	0.47
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	0.38
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	-
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	-
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	0.69
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	186.67
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	0.13
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	0.90
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	0.54
10	Savara	1.11 Bn	1.11 Bn	-	-

Download Data